Metastatic malignant melanoma presenting with hypercalcaemia and bone marrow involvement

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 4, 2006, Pages 432-434

  Batsis, John A ^a   Barry, M J ^b,c  

^a MAYO CLINIC   (United States)

^b ST JAMES S HOSPITAL   (Ireland)

^c Department of Therapeutics and Clinical Pharmacology ^*

Author keywords

Bone marrow; Hypercalcaemia; Malignant melanoma; Metastasis

Indexed keywords

ACETYLSALICYLIC ACID; BECLOMETASONE; CORTICOSTEROID; DILTIAZEM; FUROSEMIDE; ISOSORBIDE MONONITRATE; PAMIDRONIC ACID; PRAVASTATIN; SALBUTAMOL;

AGED; ANAMNESIS; ARTICLE; ASPIRATION BIOPSY; ASTHMA; BONE MARROW EXAMINATION; BONE MARROW METASTASIS; CANCER STAGING; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; HYPERCALCEMIA; HYPERTENSION; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; INTRAVENOUS ADMINISTRATION; ISCHEMIC HEART DISEASE; LYMPH NODE METASTASIS; MELANOMA; METASTASIS POTENTIAL; OSTEOARTHRITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

AGED; BONE MARROW NEOPLASMS; FATAL OUTCOME; FEMALE; HUMANS; HYPERCALCEMIA; MELANOMA; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645362487     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01435.x     Document Type: Article

References (9)

1. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century. J Am Acad Dermatol 1996; 34: 839-847.
2. Balch CM, Soong S-J, Gershenwald JE et al. Prognostic factors analysis of 17 600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-3634.
3. Savage RA, Lucas FV, Hoffman GC. Melanoma in marrow aspirates. Am J Clin Pathol 1983; 79: 268-269.
4. Brossart P, Keilholz U, Willhauck M et al. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 1993; 101: 887-889.
5. Kageshita T, Matsui T, Hirai S, Fukuda Y, Ono T. Hypercalcemia in melanoma patients associated with increased levels of parathyroid hormone-related protein. Melanoma Res 1999; 9: 69-73.
6. Attia P, Phan GQ, Duray PH, Rosenberg SA. Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma. Case report and review. Am J Clin Oncol 2003; 26: 42-45.
7. Levy I, Feun L. Hypercalcemia and malignant melanoma. Am J Clin Oncol 1990; 13: 524-526.
8. Burt ME, Brennan MF. Hypercalcemia and malignant melanoma. Am J Surg 1979; 137: 790-794.
9. Des Grottes JM, Dumon JC, Body JJ. Hypercalcemia of melanoma: Incidence, pathogenesis and therapy with bisphosphonates. Melanoma Res 2001; 11: 477-482.